GlassScriptPhysician profile
Nina Shah
NPI 1063616654
$849.16
in general payments reported to CMS, 2019-2025
14 companies · $74.13 in 2025
The $74.13 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.35 · 2020: $116 · 2021: $227 · 2022: $89.44 · 2023: $126 · 2024: $168 · 2025: $74.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $189.74 | 2019-2025 | Vaxneuvance, Gardasil 9, M-M-R II |
| Seagen INC. | $130.14 | 2021 | |
| Cranial Technologies, INC | $104.20 | 2019-2024 | Doc Band |
| Ironshore Pharmaceuticals INC. | $88.03 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $75.78 | 2023-2024 | Flumist Quadrivalent |
| Glaxosmithkline, LLC. | $58.55 | 2022-2025 | Bexsero |
| Harmony Biosciences LLC | $52.87 | 2023-2024 | Wakix |
| Phadia US INC. | $31.71 | 2021-2022 | |
| Pfizer INC. | $25.26 | 2021 | |
| Sanofi Pasteur INC. | $24.22 | 2024 | |
| Verrica Pharmaceuticals INC. | $23.22 | 2024 | Ycanth |
| Seqirus USA INC | $17.84 | 2024 | Flucelvax |
| Alk-Abello, INC | $16.07 | 2025 | Neffy |
| Genentech USA, INC. | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nina Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.